NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients.
OBJECTIVE
To investigate N-terminal pro-brain natriuretic peptide (NT-proBNP) level as a prognostic factor and a marker of myocardial dysfunction in patients with septic shock.


METHODS
Prospective observational study.


METHODS
Intensive care unit.


METHODS
A total of 39 patients diagnosed with septic shock and requiring mechanical ventilation.


RESULTS
Demographic, hemodynamic, respiratory, and biological data (notably NT-proBNP, lactate, and cardiac troponin I) were collected at inclusion and every 12 hrs. The independent factors for death were higher Sequential Organ Failure Assessment score in the 24-hr period after inclusion (odds ratio, 4.7; 95% confidence interval, 1.15-19.3) and the highest NT-proBNP level in the 24-hr period after inclusion (odds ratio, 1.12 per 1000 pg/mL increase; 95% confidence interval, 1.05-1.26). An NT-proBNP of >13,600 pg/mL predicted intensive care unit mortality with an accuracy of 77%. Area under the receiver operating characteristic curve was 0.8 (p = .002; 95% confidence interval, 0.66-0.93). NT-proBNP levels were over the accepted normal range in all patients. Values were highest between 24 and 36 hrs after onset of septic shock and were significantly higher in nonsurvivors at each time between inclusion and day 7. The lowest left ventricular stroke work index of the first 24-hr period after inclusion was the only factor that independently influenced higher NT-proBNP levels at the same time (odds ratio, 0.91; 95% confidence interval, 0.84-0.98).


CONCLUSIONS
NT-proBNP seems to be an early factor of prognosis and myocardial dysfunction in patients with septic shock.
Roch
Antoine
A
Service de Réanimation Polyvalente, Hôpitaux Sud, Marseille, France.
Allardet-Servent
Jérôme
J
Michelet
Pierre
P
Oddoze
Christiane
C
Forel
Jean-Marie
JM
Barrau
Karine
K
Loundou
Anderson
A
Perrin
Gilles
G
Auffray
Jean-Pierre
JP
Portugal
Henri
H
Papazian
Laurent
L
D000368:Aged; D001794:Blood Pressure; D009202:Cardiomyopathies / Q000097:blood*; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain; D009419:Nerve Tissue Proteins / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis; D011446:Prospective Studies; D012372:ROC Curve; D012121:Respiration, Artificial; D012772:Shock, Septic / Q000097:blood* / Q000401:mortality / Q000628:therapy; D019210:Troponin I / Q000097:blood*
D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D019210:Troponin I; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain